Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The company has not published efficacy data and did not respond to a request for information
The researchers examined the impact of these interventions through a biochemical characterization of brain homogenates, quantifying oxidative and inflammatory markers such as lipid peroxides, glutathione (GSH), glutathione S-transferase (GST), 5-lipoxygenase (5-LOX), cyclooxygenase-2 (COX-2), leukotriene B4, prostaglandin E2, and ascorbic acid using spectrophotometric assays and ELISA
The most commonly reported adverse effects in the Phase 2 trial included: Nausea the most prevalent side effect, particularly during dose escalation Vomiting Diarrhoea Constipation Decreased appetite (which, whilst contributing to weight loss, can be uncomfortable) Eructation (belching) Injection-site reactions (such as redness, bruising, or discomfort at the injection site) These effects are typically mild to moderate in severity and tend to be most pronounced during the first few weeks of treatment or following each dose increase
Protocol requires 0.05 mg per calf (0.1 mg total) post-leg training, 2x weekly minimum, for 6 weeks
Peak weight loss typically occurs between months six and 12
Assessment timelines matter significantly
US$ 26.22
US$ 21.24
US$ 24.76
US$ 21.65
-1775582746855.png&w=3840&q=75)
US$ 25.33
US$ 23.09
US$ 25.70
US$ 21.06
US$ 24.82
